Baker Bros. Advisors is a fund manager in New York with $25.71 bn assets under management.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
Former names
Baker Bros Advisors LLC
SEC CIK
IRS number
134093645
SEC advisor number
801-73446
FINRA CRD number
158149
AUM ?
$25.71 bn
(as of 28 Mar 22)
Accounts
3
(as of 28 Mar 22)
Employees
50
(15 investment advisory or research)
Address
Baker Bros. Advisors
860 WASHINGTON STREET
3RD FLOOR
NEW YORK
NY 10014
860 WASHINGTON STREET
3RD FLOOR
NEW YORK
NY 10014
Office hours
Monday - Friday, 9AM - 6PM
Phone
2123395600
Ownership
| Owner | Title | From | %Ownership |
|---|---|---|---|
| Baker, Julian, Charles | Limited Partner | 01/2000 | 25-50% |
| Baker, Felix, James | Limited Partner | 01/2000 | 25-50% |
| Lessing, Scott, Lawrence | President, Chief Compliance Officer | 02/2011 | < 5% |
| Toohey, Alexandra, Ann | Chief Financial Officer | 01/2014 | < 5% |
| Baker, Julian, Charles | Managing Member | 01/2000 | 50-75% |
| Baker, Felix, James | Managing Member | 01/2000 | 50-75% |
| Baker Bros. Advisors (GP), LLC | General Partner | 01/2000 | < 5% |
Ownership
| Fund structure | AUM | Fund type |
|---|---|---|
| Baker Brothers Investments | $25.71 bn | |
| 667, L.P. | $2.27 bn | Hedge Fund |
| Baker Brothers Life Sciences, L.P. | $23.42 bn | Hedge Fund |
| Hcif Offshore LP |
Latest filings (excl ownership)
No filings
Latest ownership filings
4
JULIAN BAKER
5 Jun 23
4
JULIAN BAKER
2 Jun 23
SC 13D/A
TScan Therapeutics, Inc.
2 Jun 23
4
JULIAN BAKER
2 Jun 23
SC 13D/A
ACADIA PHARMACEUTICALS INC
24 May 23
4
JULIAN BAKER
24 May 23
4
JULIAN BAKER
24 May 23
SC 13D/A
Prelude Therapeutics Inc
24 May 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
SC 13D/A
BeiGene, Ltd.
5 May 23